36.7K
Downloads
102
Episodes
Catch up on ’All Things Urticaria’ in this podcast series developed by Global Allergy and Asthma Excellence Network UCARE in collaboration with Medthority. Professor Marcus Maurer, Professor of Dermatology and Allergy at Charité – Universitätsmedizin Berlin, is joined by colleagues for in-depth discussions on the latest research and opinion on the pathogenesis and treatment of urticaria. Medthority received educational funding from the sponsor to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated content. The opinions in this podcast are of the invited faculty, for informational purposes only, and should not be taken as medical advice. Please consult your regional guidelines for clinical practice recommendations in your area. For updates on ’All Things Urticaria’, sign up on Medthority. For more on UCARE/ACARE activities, visit the UCARE and ACARE websites, UCARE 4U, UDAY, CRUSE Control App, and CURE Registry. Episodes 1 – 61: This content has been developed independently of the sponsor, Novartis Pharma AG. Episode 31 and 33: This content has been in collaboration with J. Uriach y Compañía S.A.
Episodes
Friday May 05, 2023
Friday May 05, 2023
Professor Karla Arruda and Professor Marcus Maurer discuss the development and implementation of UCARE in Brazil, and its potential benefits for individuals suffering from chronic spontaneous urticaria (CSU). The conversation extends towards exploring the framework of the Brazilian UCARE centres and projects, and how it can be implemented in other countries. Professor Maurer delves into the clinical efficacy, advantages, and impact on patient quality of life of utilising Bruton’s tyrosine kinase inhibitors for the treatment of CSU, along with further discussion of alternative treatments.
Access additional resources by signing up to Medthority and to be notified for future 'All Things Urticaria' podcast episodes!
Do you have suggestions for future episodes? Please visit UCARE to provide feedback via the link here and offer your suggestions for future topics and expert selection!
Tuesday Apr 25, 2023
Tuesday Apr 25, 2023
Professors Marcus Maurer and Luis Felipe Ensina deliberate on the most recent findings that emerged at The American Academy of Allergy, Asthma & Immunology (AAAAI) conference held in San Antonio, Texas. In particular, Professor Maurer discusses poster presentations concerning the efficacious use of omalizumab and dupilumab for the management of urticaria. Professor Ensina expands the discussion by outlining ongoing projects and upcoming projects within UCARE that will be presented at the forthcoming UCARE conference in São Paulo in 2023.
Access additional resources by signing up to Medthority and to be notified for future 'All Things Urticaria' podcast episodes!
Do you have suggestions for future episodes? Please visit UCARE to provide feedback via the link here and offer your suggestions for future topics and expert selection!
Thursday Apr 06, 2023
Thursday Apr 06, 2023
Dr. Murat Türk has joined Professor Marcus Maurer to discuss biomarkers in chronic spontaneous urticaria (CSU), focusing on immunoglobulin E (IgE) in particular. They emphasise the importance of using IgE testing appropriately in the treatment of CSU; as a prognostic parameter rather than a diagnostic technique. The discussion expands into a comparison between basophil testing and IgE testing and explores the implications of these results for patients with CSU.
Monday Mar 20, 2023
Monday Mar 20, 2023
Professor Marcus Maurer is joined by Dr Melba Munoz to take a deep dive into symptomatic dermographism. The discussion aims to explain the involvement of mast cells in CSU patients and attempts to answer some ongoing questions to help unravel the pathogenesis of dermographism in chronic urticaria.
Thursday Mar 02, 2023
Thursday Mar 02, 2023
Dr Pavel Kolkhir joins Professor Marcus Maurer to discuss the Chronic Urticaria Registry (CURE). The discussion includes explanations of the aims of CURE in collecting quality, real-life data on chronic urticaria patient characteristics, the course of disease, underlying causes, comorbidities, treatment responses, quality of life impairment and health care costs.
Thursday Feb 23, 2023
Thursday Feb 23, 2023
Professor Marcus Maurer is joined by Dr Jie Li to discuss the role the gut microbiome plays in the disease progression of CSU. A particular focus is given to metabolism and homeostasis in patients with CSU, how the gut microbiome can impact CSU presentation, and the impact it can have on the efficacy of treatments such as antihistamines.
Wednesday Feb 08, 2023
Wednesday Feb 08, 2023
Professor Alicja Kasperska-Zajac joins Professor Marcus Maurer to discuss a rare form of chronic inducible urticaria – delayed pressure urticaria. The discussion highlights the difficulties in undertaking differential diagnosis and the main differences when compared to chronic spontaneous urticaria, namely the absence of oedema and wheals.
Tuesday Jan 24, 2023
Tuesday Jan 24, 2023
Professor Yoshimichi Okayama joins Professor Marcus Maurer to discuss the role which mast cells play in the disease aetiology of chronic spontaneous urticaria. In particular, the discussion focuses on mast cell receptors and how they can be utilised in the diagnosis of CSU.
Monday Jan 09, 2023
Monday Jan 09, 2023
Professor Marcus Maurer is joined by Professor Asli Gelincik as they discuss recurrent angioedema in chronic spontaneous urticaria, and treatment options which are currently available to alleviate this pathology. The mechanistic actions of mast cell-mediated angioedema and bradykinin-mediated angioedema are discussed and their implications are analysed.
Monday Dec 12, 2022
Monday Dec 12, 2022
Dr Heike Röckmann, head of the drug survivability of omalizumab in chronic urticaria (DruSO-CU) project joins Professor Marcus Maurer to discuss the global project, the difficulties which were encountered, and how the UCARE network helped overcome these challenges. The focus of this podcast is on the importance of identifying the data in this important project.